Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.)

Not featured in screeners

Not featured in screeners

Top insiders

Download results Settings

McCune, Michael Grant

Senior Officer of Issuer

1 sale — total 9,540 CAD

Sale 6 Feb 2023

Value CA$4,122,649.07 | Price 330.86 | Shares 3,486

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2023-02-21	2023-02-06	S Sale	McCune, Michael Grant Senior Officer of Issuer Officer	3,486 -7.4% 330.86 CA$4,122,649	3,486 -7.4%	330.86	CA$4,122,649

More insider trading research around Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.)